Warning: Declaration of subscribe2_widget::addPluginSubMenu() should be compatible with mijnpress_plugin_framework::addPluginSubMenu($title, $function, $file, $capability = 10, $where = 'plugins.ph...') in /data/32/2/10/97/2499423/user/2737425/htdocs/wordpress1/wp-content/plugins/subscribe2-widget/subscribe2-widget.php on line 18

Warning: Declaration of subscribe2_widget::addPluginContent($links, $file) should be compatible with mijnpress_plugin_framework::addPluginContent($filename, $links, $file, $config_url = NULL) in /data/32/2/10/97/2499423/user/2737425/htdocs/wordpress1/wp-content/plugins/subscribe2-widget/subscribe2-widget.php on line 18
Gabrielle | SEBIO

RTP-based startup T3D offers hope to Alzheimer’s patients

Posted by on Feb 11, 2020 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. – In a landscape littered with disappointment in the battle against the global scourge of Alzheimer’s disease, an RTP-based company is offering a new chance for hope. T3D Therapeutics, a 7-year-old company started with loan help from the North Carolina Biotechnology Center, said today it is launching a Phase 2 clinical trial with its unique product candidate, T3D-959, to treat mild to moderate forms of Alzheimer’s disease (AD). T3D-959 is a chemically synthesized once-daily oral drug described as a brain-penetrating dual nuclear receptor agonist....

Read More

New Life-sciences Venture Contest To Award Top Grant Of $20K

Posted by on Feb 5, 2020 in Newsroom | 0 comments

WILMINGTON, N.C. – Life sciences and biotechnology business ventures in Southeastern North Carolina could get a boost through a new competition launched Tuesday by the N.C. Biotechnology Center Southeastern Office, in partnership with UNCW’s CIE. Entrepreneurs and companies can now apply for the NC BIONEER Venture Challenge, which aims to “raise the profile, increase the volume, and enhance the success of life science commercialization, entrepreneurs, and companies in the region,” according to the venture challenge website. The application period runs through Feb....

Read More

Eli Lilly returns to RTP with $470M plant for diabetes drugs

Posted by on Jan 21, 2020 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. – Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) plans to build a research facility in RTP, creating 462 jobs over the next five years, officials said Tuesday. The Indianapolis-based company will invest $474 million in the lab, which will produce drugs for diabetes. “This next-generation manufacturing facility will allow us to expand our capacity to make the Lilly medicines that are helping people with serious illnesses today and help us prepare for new medicines coming from our robust pipeline in the future,” Chairman and Chief...

Read More

KBI Biopharma teams up with AbSci to promote each other’s technologies

Posted by on Jan 14, 2020 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. — KBI Biopharma, a biopharmaceutical cAbSci, the Protein Printing™ company with a best-in-class E. coli cell line for rapid and low-cost biomanufacturing of complex biotherapeutics, today announced the completion of a $10.4M Series D financing led by KBI Biopharma and JSR Life Sciencesract services organization with offices in Durham and RTP, has entered into an exclusive co-marketing agreement with the Washington-based biopharma tech company, AbSci. The uptick: both get the privilege to jointly market and promote each other’s...

Read More

410 Medical’s LifeFlow device wins healthcare fans, major contract

Posted by on Jan 14, 2020 in Newsroom | 0 comments

RALEIGH — A hand-held fluid resuscitation device developed by Durham start-up 410 Medical has been generating major buzz and billings for its unique design and pot LifeFlow is a hand-operated infuser that combines a syringe, automatic check valve and high-flow tubing set. It was designed by physician Mark Piehl at WakeMed Health & Hospitals in Raleigh to help a single caregiver inject resuscitating fluids quickly and easily with less stress in emergency situations. The company says LifeFlow lowers risk of organ failure due to its ability to deliver fluids more efficiently. ential...

Read More